Critical Care

Clinical Description

Critical illness is a potentially reversible state of ill health with vital organ dysfunction and high risk of death. It is the most severe form of acute illness and can be due to any underlying condition, in any patient, irrespective of age.

Effective assessment of patients with suspected critical illness requires systematic evaluation of vital organ functions. Health workers should focus on the airway, respiratory, cardiovascular and neurological systems using an ABCD approach (see emergencies section). Evaluation and treatment should be conducted in parallel to rapidly stabilise the patient. The presence of any severely deranged vital sign indicates critical illness. The renal, gastro-intestinal, hepatic, dermatological and hematological systems should then be assessed to determine the type and extent of multi-organ failure (Table 1). The more organs failing, the more serious the critical illness is likely to be. Critical care specific scoring systems.

Critical care aims to restore and maintain safe (not necessarily normal) physiology to promote

Patient recovery and organ function. This involves titrated escalation and de-esclation of supportive therapies (e.g. oxygen, fluids, and antibiotics) and early recognition if care modification is required (e.g. medication change or surgery). Setting physiological targets facilitates this aim and promotes nurse- led titration (e.g. adjustment of oxygen according to saturation). Goals should be individualized for each patient and their current condition. To achieve set goals, systematic approaches should be used, incorporating the views of the multidisciplinary team. The underlying cause of disease must be managed.

MEML INDEX

PREFACE

• The MEML lists all those medicines considered to be most suitable for current use in the country. Although primarily intended for public sector application, it is equally appropriate for private sector prescribers, who are strongly encouraged to select medicines on the MEML whenever possible.

PROCEDURE FOR AMENDMENTS OF THE MEML

• Prescribers are encouraged to continually and critically review the relevance of the MEML to current clinical practice.
• Suggestions for amendments should be made through submission of a proposal in writing to:

HTSS-Pharmaceuticals, PO Box 30377, Lilongwe 3, Malawi.

Tel: (265) 01 788 371

Fax: (265) 01 788 502

• An amendment form which may be used for this purpose has been included at the end of this booklet.
• Amendments can include the addition or deletion of an item, change of dose presentation, change of categorisation code (s), change of layout of the publication, etc.)
• When sufficient proposals have been received or if urgent amendments are required, a special NMC will be convened to review these and agree on any changes to the MEML. Otherwise it is planned for the MEML to be revised once every 2 years in conjunction with the MSTG.

FOR ADVERSE REACTIONS:

Please contact the Pharmacy, Medicines and Poisons Board at info@pmra.mw

PRESENTATION OF INFORMATION

General

• Medicines names: As in previous lists, each medicines item is described by its generic name which, according to the National Medicine Policy (NMP) 2014, should be used for all prescribing and dispensing.
• Order of Sections: Medicines are arranged by pharmacological/therapeutic groups following the same basic format as the "WHO Model List of Essential Medicines – 22nd

List, 2021,” with the addition of an extra section (Number 31; Nutritional Disorders)

• Medicines numbering: each item is numbered within its section and thus can be conveniently identified by a composite number, consisting of the section number and the medicines numbers (final number):

CATEGORISATION/PRIORITISATION OF MEDICINES ITEMS

• Medicines items have again been categorised using a three letter coding system according to the:

approved level of use (H, D or C) therapeutic priority (V or E) procurement system (A or B)

• Such categorisation is intended to facilitate the prioritisation of selection and subsequent procurement of drugs both by Central Medical Stores Trust (CMST) and user units.

LEVEL OF USE CODE (H, D, OR C)

• This indicates the level of Health Institution at which the item would normally be permitted for use:

H = Health Centre level (i.e. for use throughout the health system at Health

Centre, District Hospital and Central Hospital levels).

D = District Hospital level (i.e. for use at District Hospital and Central

Hospital levels only)

C = Central Hospital level (i.e. for use at Central Hospital level only)

Thus C drugs should not normally be used at D and H levels, and D drugs should not normally be used at H level.

However, there are possible exceptions to this general rule:

• Additional clinical expertise: if this is available at H level (e.g. An Ophthalmic Medical

Assistant, Psychiatric Enrolled Nurse/Midwife, Clinical officer, etc.), certain D level drugs may be made available for use by that particular prescriber. This however, will be at the discretion of the Director of Health and Social Services (DHSS). Written authorisation should be given to the named prescriber by the DHSS, listing the drugs authorised and a copy of this sent to the Chief of Health Services (CHS).

• Special clinical expertise: Certain DHOs may have access to specialised clinical expertise in one or more areas and must request their Regional Medical Stores to make available certain C level drugs for use at the particular district hospital.

Authorisation stating name of prescriber, specialty and specified drugs, should be sought in writing from the Chief Executive Officer of CMST.

• Maintenance treatment: Individual patients being treated for chronic conditions may have arrangements made for them to receive maintenance treatment with the required D or C level drugs at H level. In these cases, such arrangements should be authorised by the DHSS and formalised in writing (named patient specified drug/s and duration of treatment) with a copy retained at the district.

THERAPEUTIC PRIORITY CODE (V, E)

This code identifies the therapeutic importance of each item using the VEN system as follows:

• V (Vital) drugs which: are potentially life-saving have significant withdrawal side- effects making regular supply mandatory. Are of major public health importance (e.g. needed by many patients for treatment of serious. contagious diseases, needed to control epidemics, etc.)
• E (Essential) drugs which: are effective against less severe, but nevertheless significant forms of illness

PROCUREMENT SYSTEM CODE (A OR B)

This third code specifies how items will be procured by CMST and by the user units.

• A - Listitems: They are generally required for large numbers of patients. Will be routinely procured and stocked by CMST Include all H level drug.

Note: Where funds for procurement are insufficient, first priority will be given to the procurement and supply of Vital) A- list items (see 2.2 above) i.e. those of the highest therapeutic importance. If funds remain after securing such VA items, procurement of (Essential) A - list items will then be initiated. Thus, ensuring the availability of A-list items is primarily the responsibility of CMST.

• B - Listitems: They are generally required for limited number of patients. Will NOT be routinely procured and stocked by CMST. Estimates of annual requirements for these will have to be made well in advance by the hospitals and submitted to CMST through the Pharmaceutical section of the HTSS, according to a pre-agreed time schedule. Payment for these must also be made in advance prior to procurement by

CMST and subsequent supply to the hospitals. Thus procurement of B-list items is primarily the responsibility of the user units. Each user unit must carefully consider the total annual budget allocated for medicines and medical supplies and make appropriate allocations for other categories. It should be clearly understood that the ultimate decision as to which items to select/procure lies with the user units.

The categorisation of items by the NMC by therapeutic priority (see 2.2 above) should facilitate this selection process and is intended to help ensure the continuous availability of the most important (i.e. VA) items.

EMERGENCY ORDERS

• Because of the limited numbers of patients involved, some potentially life-saving medicines on the MEML are categorised as VB items.
• Following established procurement priorities, CMST will not therefore routinely stock these (B-list) items. Ideally user units should keep small contingency stocks of such items to cover emergencies. However, if necessary, special emergency orders can be placed (initially by phone or fax and then followed up by a written requisition with CMST for identified lifesaving VB drugs.
• These orders, which must be authorised by the DHSS and countersigned by the Regional Medical Stores Pharmacist in Charge and will not require advance payment, as with other B-list medications. User units will be promptly notified if CMST is unable to procure and deliver these items within 24hrs.

LISTING BY CATEGORY/PRIORITY WITHIN SECTIONS

• In order to make the MEML easier to use by different levels of health institution, drugs are listed by generic name within individual sections and subsections according to the following order of priority.

H level then D level then C level.

Within each level the listing is V (vital) then E (essential) drugs which are on the A list for procurement (i.e. always stocked by CMST) followed by V (vital) then E (essential) drugs which are on the B list for procurement (i.e. only stocked if ordered/paid for in advance)

ABBREVIATIONS amp = ampoule aq = aqueous cap = capsule

CHSU = Community Health Sciences Unit, Lilongwe

CMST = Central Medical Stores Trust

COM = College of Medicine

EO = emulsifying ointment g = gram

HTSS = Health Technical and Support Unit inj = injection

IU = international units

IM = intramuscular

IV = intravenous

KCH = kamuzu Central Hospital

L = litre

Mcg = Microgram mg = milligram mixt = mixture mL = millilitre

MOH = Ministry of Health

MU = mega (million) units oint = ointment paed = paediatric

PFR = powder for reconstitution

PIH = pregnancy - induced hypertension

PMRA = Pharmacy and Medicines Regulatory Authority

QECH = Queen Elizabeth Central Hospital, RMS = Regional Medical Stores

SC = subcutaneous or sugar-coated as appropriate soln = solution susp = suspension tab = tablet vag = vaginal

YSP = yellow soft paraffin %v/v = percentage volume in volume

ZCH = Zomba Central Hospital

ZMH = Zomba Mental Hospital

Malawi Essential Medicine List

• 1. ANAETHESTICS, PREOPERATIVE MEDICINE AND MEDICAL GASES 1.1 General Anaesthetics and Oxygen 1.1.1 Inhalation

Halothane inhalation DVA

Isoflurane inhalation DVA

Nitrous Oxide inhalation CEB

Sevoflurane inhalation CEB

Oxygen inhalation (medical gas) DVA 1.1.2 Intravenous Medicines

Ketamine inj, 50mg/ml, 10ml, amp DVA

Propofol inj, 2%, 50ml, vial CVA

Thiopentone inj, 500mg vial, PFR DVA 1.2 Neuromuscular blockers & Anticholinesterase

Atracurium inj, 10mg/ml, 5ml amp CEB

Neostigmine inj, 2.5mg/ml, 1ml amp DVA

Rocuronium inj, 10mg/ml, 5ml vial CEB

Suxamethonium inj, 50mg/ml, 2ml, amp DVA

Vecuronium inj, 10mg vial, PFR DVA

Morphine Sulphate inj, 2mg/ml, 50ml vial CVA 1.3 Opioid analgesia

Fentanyl inj, 50mcg/ml, 10ml CEB

Morphine sulphate inj, 2mg/ml, 50ml vial CVA

Nalbuphine inj, 20mg/ml, 10ml, vial CEB

Pethidine inj, 50mg/ml, 2ml amp DVA 1.4 Local Anaesthetics

Bupivacaine isobaric inj, 5%, 10ml amp DVA

Bupivacaine (heavy) + Glucose inj, 5mg+80mg/ml, 4ml amp DVA

Lignocaine HCI inj, 2%, 20 ml vial DEA

Lignocaine HCI spray, 10% CEB

Lignocaine HCI gel, 2%, 30 g tube DEA

Lignocaine HCl + Adrenaline Dental catridges, 2% + 1/80000, 2.2ml HEA

Ropivacaine Inj, 7.5mg/ml, 10ml amp CEB 1.4 Preoperative medications and sedation medications for short procedures

Amiodarone inj, 30mg/mL, 10mL CVA

Atropine sulphate inj, 600 mcg/mL, 1mL amp DVA

Dobutamine inj, 12.5mg/mL, 20mL amp CVA

Ephedrine inj, 30mg/mL, 1mL amp DVA

Epinephrine inj, 100mcg/ml, 10ml amp DVA

Metoclopramide inj, 5mg/ml, 2ml, amp CEB

Pethidine Inj, 50mg/ml, 2ml, amp DVA

Phenylephrine inj, 10mg/mL, 1mL amp CEB

Promethazine tab, 25mg DEA

Promethazine inj, 25mg/ml, 2ml, amp DEA 2 MEDICINES FOR PAIN AND PALLIATIVE CARE 2.1 Non Opioids and non-steroidal anti-inflammatory Drugs (NSAIDS)

Aspirin tab, 300 mg HVA

Diclofenac sodium tab, 50 mg DEA

Ibuprofen tab, 200 mg DEA

Indomethacin tab, 25 mg HEA

Mefenamic acid cap, 250mg DVA

Paracetamol elixir 125mg/ml HVA

Paracetamol tab, 500 mg HVA

Tranexamic acid tab, 500mg DEB 2.2 Opioid analgesics

Codeine phosphate tab, 15 mg DVA

Dihydrocodeine tartrate tab, 30 mg DEA

Fentanyl 12.5mcg, Patches CEB

Morphine sulphate strong soln, 10mg/ml DVA

Morphine sulphate weak soln, 5mg/5ml DVA

Morphine sulphate inj, 15 mg/ml, 1 ml amp DVA

Morphine sulphate tab, slow-release, 10 mg DVB

Naloxone HCI inj, 20mcg/ml, 2ml ampl DEA

Pethidine HCI inj, 50 mg/ml, 2 ml amp DVA

Tramadol cap, 50mg DEB 2.3 Medicines used for other common symptoms for palliative care

Amitryptiline tab, 25mg HVA

Baclofen tab, 5mg DEB

Bisacodyl tab, 5mg DEA

Bupivacaine inj, 1mg/ml ampoule CVA

Carbamazepine liquid, 100mg/5ml HVA

Chlopromazine tab, 25mg HVA

Dexamethasone inj, 4mg/ml,1 ml ampoule DEB

Dexamethasone tab, 0.5mg DEB

Diazepam inj, 5mg/ml DVA

Diazepam tab, 5mg DVA

Fluconazole tab, 200mg DVA

Gabapentine cap, 300mg DVA

Glycerine Suppositories tab, Rectal DEB

Haloperidol tab, 0.5mg DEA

Hyoscine Hydrobromide inj, 400mcg/ml CEB

Lactulose liquid, 3.1-3.7g/5ml CVB

Liquid Paraffin 500ml HEA

Loperamide tab, 2mg DEB

Metoclopramide tab, 10mg DEB

Multivitamin tab HVA

Ondansetron tab, 4mg DEB

Phenytoin tab, 100mg HVA

Prednisolone tab, 5mg DVA

Promethazine tab, 25mg DEA

Senna liquid, 7.5mg/5ml DVB 3 ANTI-ALLERGICS AND MEDICINES USED IN ANAPHYLAXIS

Adrenaline inj, 1mg/ml, 1ml amp DVA

Cetirizine tab, 10mg DEB

Chlorpheniramine maleate tab, 4 mg HEA inj, 10mg/ml DEA

Dexamethasone inj, 4mg/ml,1 ml ampoule DEB

Hydrocortisone inj, 50mg/ml, vial DVB

Phenylephrine inj, 10mg/mL, ampoule DVB

Prednisolone tab, 5mg DVA

Promethazine tab, 25 mg HVA

Promethazine HCI inj, 25 mg/ml, 2 ml amp DEA

Salbutamol nebuliser, 5mg/ml, vial DVA 4 ANTIDOTES AND OTHER MEDICINES USED IN POISONING 4.1 Non Specific

Activated Charcoal Powder DVB 4.2 Specific

N-Acetycysteine inj, 200 mg/ml, 10 ml amp DVB

Atropine sulphate inj, 600 mcg/ml, 1ml amp DVA

Darrows half strength Infusion, 1L with 5% glucose CVB

Desferrioxamine inj, 500 mg vial (PFR) DVB

Dextrose Infusion, 5% 1L HVA

Ipecacuanha emetic mixture, paediatric HEA

Pralidoxime mesylate inj, 200 mg/ml, 5 ml amp CVB

Sodium Bicarbonate tab, 650mg CVB

Sodium Chloride infusion, 0.9%, 1l HVA 5 ANTICONVULSANT/ANTIEPILEPTIC MEDICATIONS

Carbamazepine tab, 200 mg DEB

Diazepam inj, 5 mg/mL, 2 mL amp DVA

Ethosuximide cap, 250 mg CEB

Levetiracetam tab, 500mg CEB

Levetiracetam inj, 500mg/5ml CEB

Magnesium sulphate inj, 500 mg/m, 2 mL amp DVA

Paraldehyde inj, 10 mL amp HVA

Phenobarbitone sodium tab, 30 mg HVA

Phenobarbitone sodium inj, 200 mg/mL, 1 mL amp HVA

Pheytoin sodium tab, 100 mg DVA

Phenytoin sodium inj, 50mg/ml, amp DVA

Sodium valproate tab, 200 mg CVB 6 ANTI-INFECTIVES MEDICINES 6.1 Antihelminthics 6.1.1 intestinal antihelminthics

Albendazole tab, 200mg HEA

Mebendazole tab, 500mg HEA

Niclosamide tab, chewable, 500mg DEB 6.1.2 antifilarials

Ivermectin tab, 6mg HVB 6.1.3 Antischistomal and other antitrematode medicine

Praziquantel tab, 600mg HEA 6.2 Antibacterials

To assist in the development of tools for antibiotic stewardship at local, national and global levels and to reduce antimicrobial resistance, the Access, Watch, Reserve (AWaRe) classification of antibiotics was developed – where antibiotics are classified into different groups to emphasize the importance of their appropriate use.

Access group: This group includes antibiotics that have activity against a wide range of commonly encountered susceptible pathogens while also showing lower resistance potential than antibiotics in the other groups. Selected Access group antibiotics are recommended as essential first or second choice empiric treatment

Watch group: This group includes antibiotic classes that have higher resistance potential and includes most of the highest priority agents among the Critically Important antimicrobials for Human Medicine. These medicines should be prioritised as key targets of stewardship programs and monitoring.

Reserve group: This group includes antibiotics and antibiotic classes that should be reserved for treatment of confirmed or suspected infections due to multi-drug-resistant organisms.

Reserve group antibiotics should be treated as “last resort” options.

ACCESS GROUP MEDICINES

Aminoglycosides

Amikacin inj, 1g vial,PFR CVA

Gentamicin inj, 40mg/ml, 2ml vial HVA

Amphenicols

Choramphenicol inj, 1g vial,PFR HVA

Cephalosporins

Cefalexin cap, 250mg DVA

Cefazolin inj, 1g vial,PFR CVA

Imidazoles

Metronidazole tab, 200mg HVA

Metronidazole inj, 5mg/ml, 100ml infusion DVA

Metronidazole Suspension 200mg/5ml HVA

Lincosamides

Clindamycin cap, 150mg DEB

Nitrofurantoin

Nitrofurantoin tab, 50mg DEA

Nitrofurantoin Suspension 25mg/5ml DVB

Penicillins

Amoxicillin cap, disp 250mg HVA

Amoxicillin elixir, 125mg/5ml HVA

Amoxicillin/Clavulanic Acid tab, 500mg + 125mg

CEA inj, 1.2g vial, PFR

Ampicilin inj, 250mg vial, PFR DVA

Benzathine benzylpecillin inj, 1.44g vial PFR (2.4 MU) HVA

Benzylpenicillin inj, 3g vial, PFR (5MU) HVA

Cloxacillin cap, 250mg DEA

Flucloxacillin cap, 250mg

DVA elixir, 125mg/5ml inj, 250mg vial, PFR

Procaine benzylpenicillin inj, 4.8 MU, vial CVB

Sulfamethoxazole/trimethoprim

Co-trimoxazole tab, 480mg HVA

Tetracyclines

Doxycycline tab, 100mg HVA

WATCH GROUP MEDICINES

Aminoglycosides

Neomycin tab, 500mg DEB

Beta lactamase inhibitor Piperacillin/Tazobactam inj, 4g + 500mg vial, PFR CEB

Carbapenems

Imipenem/Cilastatin inj, 250mg + 250mg PFR CVA

Meropenem inj, 500mg vial, PFR CVA

Cephalosporins

Cefotaxime inj, 500mg, PFR DVA

Cefipime inj, 1g vial,PFR DVA

Cefixime tab, 250mg DVA

Cefuroxime tab, 500mg DVA

Cefriaxone inj, 1g vial,PFR DVA

Ceftazidime inj, 1g vial,PFR CVB

Glycopeptides

Vancomycin inj, 1g vial,PFR CVA

Vancomycin cap, 250mg DVB

Fluoroquinolones

Ciprofloxacin tab, 250mg

DVB inj, 200mg/100ml

Levofloxacin tab, 250mg CVA

Macrolides

Azithromycin

Tab, 500mg

DEA

Suspension, 200mg/5ml

Clarithromycin tab, 500mg CVA

Clarithromycin Suspension,125mg/5ml CVA

Quinolones

Nalidixic acid tab, 500mg DVA

Rifamycins

Rifampicin cap, 150mg DVB

Steroid antibacterial

Fusidic Acid Cream, 2%w/w, 20gm tube CVB

Sodium fusidate tab, 250mg CVB

RESERVE GROUP MEDICINE

Oxazolidinones

Linezolid Inj, 2mg/ml, 300ml vial CEB 6.2.3 Antileprosy medicines

Clofazimine cap, 50mg DVA

Dapsone tab, 100mg DVB

Rifampicin caps, 150mg DVB 6.2.4 Antituberculosis medicines

Bedaquiline tab, 100mg DVA

Clofazimine tab, 50mg, 100mg DVA

Cycloserine cap, 125mg, 250mg CVB

Delamanid tab, 50mg DVA

Ethambutol tab, 400mg DVA

Ethionamide tab, 250mg CVA

Isoniazid tab, 100mg, 300mg DVA

Levofloxacin tab, 100mg, 250mg DVA

Linezolid tab, 600mg DVA

Pretomanid tab, 200mg DVB

Prothionamide tab,250mg DVB

Pyrazinamide tab, 400mg DVA

Rifapentine tab, 150mg DVA 6.3 Antifungal medicines

Liposomal amphotericin B inj, 50mg vial, PFR CVA

Cotrimazole pessary, 500mg DEA

Fluconazole cap, 200mg

DVA

IV infusion, 2mg/ml, 100ml

Suspension, 10mg/ml

Flucytosine tab, 100mg DEA

Gentian violet paint, 0.5%, 500ml HEA

Griseofulvin tab, 125mg, 250mg, 500mg DEA

Nystatin pessary, 100000 units/tab

HVA

Suspension, 100000 units/ml

Ketoconazole tab, 200mg DVA

Itraconazole tab,100mg CEB

Miconazole pessary, 200mg CVA

Terbenafine tab, 250mg

CVB

Cream, 1%w/w, 20gm tube 6.4 Antiviral medicines 6.4.1 Antiherpes medicine

Aciclovir tab, 200mg HVA cream, 5%w/w, 10g

Ganciclovir inj, 500mg, PFR

CEB tab, 500mg 6.4.2 Antiretroviral 6.4.2.1 Nucleoside reverse transcriptase inhibitors 6.4.2.2 Non-nucleoside reverse transcriptase inhibitors

Efavirenz (EFV) tab, 600mg HVA

Neverapine (NVP) Suspension 10mg/ml, 240ml HVA 6.4.2.3 Protease inhibitors

Atazanavir/Ritonavir tab, 300mg/100mg HVA

Darunavir tab, 75mg, 150mg,600mg CVA

Lopinavir/Ritonavir (LPV/r) tab, 200mg/ 50mg, DVA 6.4.2.4 Intergrase Inhibitor Dolutegravir tab, 10mg,dispersible HVA

Dolutegravir tab, 50mg HVA 6.4.2.5 Fixed dose combinations 6.4.2.5.1 Pediatric Anti-HIV medicines

Abacavir/Lamivudine tab, 120mg/60mg, dispersible HVA

Zidovudine/Lamivudine tab, 60mg/30mg, dispersible HVA

Neverapine/Zidovudine/Lamivudine tab, 50mg/60mg/30mg, dispersible HVA

Lopinavir/Ritonavir (LPV/r) tab, 100mg/25mg DVA 6.4.2.5.2 Adult Anti-HIV medicines

Abacavir/Lamivudine tab, 600mg/300mg DVA

Tenofovir/Lamivudine tab, 300mg/300mg HVA

Tenofovir/Emtricitabine tab, 300mg/200mg HVA

Lamivudine/Zidovudine tab, 150mg/300mg HVA

Lamivudine/Tenofovir/Dolutegravir tab, 300mg/300mg/50mg HVA

Efavirenz/Lamivudine/ Tenofovir tab, 400mg/300mg/300mg HVA

Atazanavir/Ritonavir tab, 300mg/100mg DVA

Lopinavir/Ritonavir tab, 200mg/ 50mg DVA 6.5 Antiprotozoal medicines 6.5.1 Antiamoebic and Antigiardiasis medicines

Metronidazole tab, 200mg

HVA

Suspension, 200mg/5ml

Praziquantel tab, 600mg HEA 6.5.2 Antileishmaniasis medicines

Amphotericin B inj, 50mg, vial CEB

Fluconazole tab, 200mg DVA 6.5.3 Antimalarial medicine 6.5.3.1 For curative treatment

Artemether+ Lumefantrine tab, 20mg + 120mg HVA

Artesunate + Amodiaquine tab, 25mg + 67.5mg DVA

Artesunate + Amodiaquine tab, 50mg + 135mg DVA

Artesunate + Amodiaquine tab, 100mg + 270mg DVA

Artesunate Bicarbonate inj, 60mg vial CVB

Artesunate Rectal Suppository, 50mg HVA

Artesunate Rectal Suppository, 100mg HVA

Artesunate Rectal Suppository, 400mg HVA

Halofantrine suspension, 100 mg/5 mL CVB

Quinine dihydrochloride inj, 300 mg/mL, 2ml amp HVA

Quinine sulphate tab, 300mg DVA 6.5.3.2 For prophylaxis

Atovaquone + Proguanil 250mg/100mg CEB

Chloroquine tab, 150mg DVB

Sulphadoxine + Pyrimethamine tab, 500mg + 25mg HVA

Proguanil HCI tab, 100 mg DVA

Mefloquine HCL tab, 250mg CEB 6.5.4 Antipneumocytosis and Antitaxoplasmosis

Co-trimoxazole tab, 480mg HVA 6.5.5 Ant-trypanosomal medicines (AFRICAN)

Melarsoprol B inj, 3.6% solution, 5mL amp DVB

Suramin sodium inj, 1 g vial PFR DVB 7 ANTI-MIGRAINE MEDICINES 7.1 For treatment of acute attack

Paracetamol tab, 500 mg HVA

IV infusion, 5mg/ml, 100ml DVA

Ibuprofen tab, 200 mg DVA

Morphine Sulphate tab, 10 mg (slow release) DVA 7.2 For prophylaxis

Amitriptyline tab, 25 mg DVA

Carbamazepine tab, 200 mg DVA

Propranolol HCI tab, 40 mg DVA

• 8. Antineoplastic and Immunosuppressant medicines 8.1 Immunosuppressive medicines

Aziothioprine inj, 50mg vial, PFR CVB

Cyclosporin cap, 25mg, 100mg CVA

Prednisolone tab, 5mg DVA 8.2 Cytoxic and Advuvant medicines 6-mercaptopurine tab, 50mg CVA

Abiraterone tab, 250mg CVB

Actinomycin D inj, 500mcg, PFR vial CVB

Adriamycin/doxorubicin inj, 50mg vial PFR CVA

Aflibercept inj, 2mg/0.05ml CEB

Anastrazole tab, 1mg CVA

Bevacizumab inj, 25mg/ml, amp CEB

Bleomycin inj, 15 IU vial PFR CVA

Bortezomib inj, 3.5mg, vial CVB

Busulphan tab, 2 mg CVB

Cabazitaxel inj, 60mg/1.5ml,vial CEB

Capecitabine tab, 500mg CVA

Carboplatin inj, 50 mg/5 ml, vial CVB

Cetuximab inj, 2mg/ml, vial CVB

Chlorambucil tab, 2 mg CVB

Cisplatin inj 50mg/50ml, vial CVB

Cyclophosphamide tab, 50 mg

CVA inj, 200 mg vial PFR

Cyclosporin cap, 100mg CVB

Cytarabine inj, 100mg/mL, amp CVB

Docetaxel inj, 20mg/ml, vial CVA

Daunorubicin HCL inj, 20mg, vial CVB

Darcabazine inj, 100mg/mL, PFR, vial CVB

Doxorubicin inj, 2mg/ml, vial CVA

Denosumab inj, 60mg/ml, vial CEB

Enzalutamide tab, 40mg CEB

Etoposide inj, 20 mg/ml, ampoule CVB

Fludarabine Phosphate inj, 50mg, vial CVB

Fluorouracil inj 500mg/10ml, ampoule CVB

Gemcitabine inj, 200mg, PFR vial CVB

Goserelin inj, 10.8mg, vial CVB

Hydroxyurea tab, 500mg CVB

Ifosphamide inj, 1 g vial, PFR. CVB

Imatinib mesylate tab, 400mg CVA

L-asparaginase inj, 10000 IU, vial CVA

Lenalidomide tab, 10mg CVB

Leucovorin inj, 10mg/mL, ampoule CVA

Lestrozole tab, 2.5 mg CVA

Melphalan tab, 2 mg CVB

Methotrexate inj, 2.5. mg/mL, amp

CVA tab, 2.5 mg

Nilotinib tab, 200mg CVB

Paclitaxel inj 300mg/50ml, vial CVB

Pomalidomide tab, 4mg CVB

Procarbazine cap, 50mg CVB

Ranibizumab inj, 2mg/0.05ml CEB

Rituximab inj, 10mg/ml, vial CVB

Taxotere (Docetaxel) inj, 40mg/ml, 2ml vial CVB

Trastuzumab inj, 440mg, PFR vial CEB

Vinblastine inj, 1mg/mL, PFR, 10mL vial CVB

Vincristine sulphate inj, 1 mg vial PFR DVA

Zolendronic acid inj, 4mg/5ml,ampoule CVA 8.3 Hormones and Antihormones

Anastrazole tab1mg CVB

Bicalutamide tab,50mg CVB

Fludrocortisone tab, 100mcg CVB

Tamoxifen tab, 40mg

CVB susp, 10mg/5ml 9 ANTIPARKISONISM MEDICINES

Benzhexol HCI tab, 5 mg DEA

Bromocriptine tab, 2.5. mg CEB

Biperiden tab 2mg CEB

Levodopa + carbidopa tab, 250 mg + 25 mg CEB

Orphenadrine tab, 50mg CEB 10 MEDICINES AFFECTING THE BLOOD 10.1 Antianaemic medicines

Ferrous sulphate + Folic acid tab, 200 mg + 0.5 mg HVA

Ferrous fumirate tab, 200mg HEA

Ferrous sulphate mixt, paed, 60 mg/5 mL HEA

Folic acid tab, 5 mg HVA

Hydroxocobalamin inj, 1 mg/mL, 1ml amp CVB

Iron dextran inj, 10%, 100mg/ml CVB

Iron sorbitol inj, (50 mg/mL), amp DVB iron sucrose inj, 20mg/ml CEB

Vitamin B12 inj, 1000mcg/ml, Vial CVA 10.2 Medicines affecting coagulation

Clopidogrel tab, 300mg CEB

Dabigatran tab, 150mg CEB

Enoxaparin inj, 4000IU/ml CVA

Heparin sodium inj, 5,000, IU/mL, vial CEB

Phytomenadione inj, 1 mg/0.5 ml, ampoule DVA

Phytomenadione inj, 10mg/mL, ampoule CEA

Protamine sulphate inj, 10 mg/mL, ampoule CEB

Rivaroxaban tab, 20mg CEB

Streptokinase inj, 1500000IU/vial CEB

Tranexamic acid tab, 250 mg CEB

Tranexamic acid inj, 500mg, ampoule CEB

Warfarin sodium tab, 1 mg CVB

Warfarin sodium tab, 5 mg CVB 10.3 Medicines to treat hyperkalemia

Pottasium binding resins podwer, 15g DVA

• 11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES 11.1 Blood products

Cryoprecipitate inj, 30-40mls DVA

Fresh frozen plasma inj, 200-300mls DVA

Random donor platelet inj, 50-70ml CEB

Red cell suspensions inj, 280-420mls

DVA inj, 100-200mls

Whole blood inj, 450mls (405-495)

DVA inj, 100-225mls 11.2 Plasma derived products

Factor viii inj, 250 IU, vial CEB

Factor ix inj, 500IU/10ml, vial CEB 11.3. Transfusion alternatives

Erythropoietin inj, 4000IU/ml CEB

IV Iron inj, 20mg/ml CEB

Haemacel inj, 3.5%, 500ml DVA 12 CARDIOVASCULAR MEDICINES 12.1 Antianginal medicines

Amlodipine tab, 5mg DVA

Atenolol tab, 50mg DVA

Glyceryl trinitrate tab (sublingual), 500 mcg DEB

Isosorbide dinitrate tab, 10 mg DEB

Nifedipine tab, 10 mg DVA

Nifedipine tab, slow-release, 20 mg DVA

Propranolol HCI tab, 40 mg DVA 12.2 Antiarrhythimic medicines

Adenosine inj, 3mg/ml, ampoule CEB

Amiodarone inj, 50mg/ml CEA

Propranolol tab, 40mg DVA

Lignocaine inj, 1%, 2 % CEB

Verapamil tab, 40mg CEB 12.3 Antihypertensive medications

Amlodipine tab, 5mg DVA

Atenolol tab, 50mg or 100mg DVA

Bendrofluazide tab, 5mg DVA

Bisoprolol tab, 5mg CVB

Captopril tab, 12.5 mg CVB

Carvedilol tab, 12.5mg CVA

Enalapril tab, 2.5 mg DVA

Enalapril tab, 5 mg DVA

Hydralazine HCI inj, 20 mg amp PFR DVA

Hydralazine HCI tab, 25 mg DEA

Hydrochlorothiazide tab, 25mg DVA

Indapamide tab, 2.5 mg CEB

Labetalol inj, 5mg/ml, ampoule CVA

Lisinopril tab, 10mg DVA

Losartan tab, 25mg CVB

Methyldopa tab, 250 mg DEA

Metoprolol tab,50mg CEB

Nebivolol tab, 5mg CEB

Nifedipine cap, 10 mg DVA

Nifedipine tab, slow-release, 20 mg DVA

Nimodipine tab, 30mg CEB

Nimodipine inj,0.2mg/ml, amp CVB

Telmisartan tab, 40mg, 80mg CVB

Prazosin tab, 1 mg CEB

Propranolol HCI tab, 40 mg DVA

Sodium nitroprusside inj, 25mg/ml CEB

Verapamil tab, 40mg CEB 12.4 Medicine used in heart failure

Digoxin tab, 250mcg, 62.25mcg

DVA inj, 250mcg/ml, ampoule elixir, 50mg/ml

Dopamine inj, 40mg/ml, vial CEB

Enalapril tab, 5mg DEB

Epinephrine inj, 100mcg/ml, ampoule DEB

Frusemide tab, 40mg HVA

Furosemide inj, 10mg/ml, ampoule DVA

Glyceryl trinitrate tab (sublingual), 500 mcg DEB

Isosorbide dinitrate tab, 10 mg DEB

Metoclopramide inj, 5mg/ml, ampoule DEA

Metolazone tab, 5mg CEB

Morphine inj, 1mg/ml, amp DVA

Spironolactone tab, 25 mg DVB 12.5 Antithrombotic medicine

Acetylsalicyclic acid tab, 75mg DVA 12.6 Lipid Lowering Agent

Artovastatin tab, 20mg CEA

Rosuvastatin tab, 10mg CEA

Simvastatin tab, 20mg CEA 12.7 Antihypotensive medicines

Dopamine HCI inj, 40 mg/mL, ampoule CVB

Ephedrine sulphate inj, 30 mgmL, ampoule DVA 13 Dermatological medicines (Topical) 13.1 Antifungal medicines

Benzoic acid + Salicylic acid oint, 6% + 3%, 500 g HEA

Clotrimazole cream, 1%, 20g DEA

Econazole cream, 1%,30g DEA

Sodium thiosulphate lotion, aq., 10%, 500 mL DEA

Miconazole cream, 2%, 30g DEA 13.2 Anti-infective Medicines

Calamine lotion + Sulphur 2% lotion, aqueous, 500 mL HEA

Chloherxidine soln, 0.2%, 500ml DVA

Gentian violet paint, aq., 0.5%, 500 ml HEA

Hydrogen peroxide soln, 3%v/v, 500 mL DEB

Iodine soln, weak, 500 mL DEA

Potassium permanganate 3%, 500 mL HEA

Povidone iodine soln, 10%, 500ml DEA

Salicylic acid + Sulphur oint, 5% + 5%, 500g (in YSP base) HEA

Salicylic acid + Sulphur ointn, 5% + 5%, 500 g (in EO base) CEB

Silver sulphadiazine cream, 1%, 500 g CEB

Zinc ointment + Sulphur oint, 5%, 500 g; paste DEA 13.3 Anti-inflammatories and Antipruritic medicines

Calamine lotion + Sulphur 2% lotion, aq, 500 mL HEA

Hydrocortisone oint, 1%, 15 g DEA

Betamethasone oint, 0.15%, 15g CEB

Calamine lotion, aq, 500 mL CEB

Clobetasol propionate oint, 0.05%, 30g CVB 13.4 Medicines affecting skin differentiation and proliferation

Benzoyl peroxide gel, 5%, 30 g DEA

Crude coal tar 10% oint, 500 g CEB

Dithranol 0.5% in zinc + Salicyclic acid paste paste, 500g CEB

Podophyllum resin paint, alcoh, 15%, 20 mL DEA

Salicylic acid lotion, 5%, 500 mL (in alcohol 70%) DEA

Salicylic acid oint, 10%, 500 g DEA

Salicylic acid oint, 20%, 500 g (in YSP base) CEA

Salicylic acid 2% + Coal tar solution 15% shampoo, 500 mL (in soap spirit) DEA

Salicylic acid collodion, 12% DEA

Salicylic acid + crude coal tar 5% oint, 500g( in YSP) CEB

Zinc compound + coal tar solution 5% paste, 500g CEB 13.5 Scabicides and Pediculocides

Benzyl benzoate application, 25%, 500 mL HEA

Lindane cream/lotion 1% CEB

Permethrine cream, 5%w/w, 20g DVB 13.6 Other topical preparations

Emulsifying ointment oint, 500 g HEA

Ethyl Chloride spray, 3% HEA

Silver nitrate pencil toughened, 40% DEA

Yellow soft paraffin oint, 500g DEA

Zinc oxide (in EO base) oint, 15%, 500 g HEA 14 DIAGNOSTIC AGENTS 14.1 Ophthalmic Medicines

Fluorescein Sodium Eye drops, 1% DEA 14.2 Radiocontrast media

Barium sulphate susp oral, 98%, 340 g pack PFR, DEA susp oral for CT; 21% package btle

CEB susp, for CT colonoscopy 40%;kit enema, disposable, 93%, 400g pack

Effervescent agent (carbex) granules(oral), 25 g sachet

CEB soln(oral), bottle

Ferumoxide MRI-TAgent) CEB

Gastrografin susp, (oral/rectal) 100g CEB

Golytely electrolyte solution (Polyethylene gycol) CEB

Magnevist inj, 0.5mmol/ml, 100ml vial (gadopentetatedimeglumine; MRI-T1 Agent)

CEB

Prohance (gadoteridol 379; MRI-T1 agent CEB

Resolvist Iron oxide anoparticles CEB

Nullytely electrolyte solution PEG 660g CEB

Urografin 60%/ 70% CEB

Ultravist/iopromide 300mg/ml, 370mg/ml CEB

Visipaque inj, 625mg/ml CEB

Xenetic inj, 250mg, 300mg, 350mg, vial CEB

X-prep liquid bottle, 130mg CEB 15 DISINFECTANTS AND ANTISEPTICS

Black disinfectant soln, for dilution HVA

Cetrimide + Chlorhexidine soln, 15% + 1.5% HVA

Chloherxidine soln, 0.2%, 500ml DEB

Glutaraldehyde soln, buffered, 2% DEA

Hydrogen peroxide soln, 3%v/v, 500 mL DEB

Povidone iodine soln, 10%, 500ml DVA 16 GASTROINTESTINAL MEDICINES 16.1 Anti acids and Anti-ulcer medicines

Cimetidine tab, 400 mg CVB

Bismuth chelate liquid, 120 mg/5 mL, 560 mL CEB

Magnesium trisilicate tab, chewable HEA

Omeprazole tab, 10mg DVA 16.2 Antiemetic medicines

Cyclizine tab, 25mg CEB

Metoclopramide HCI inj, 5 mg/mL, 2 mL amp DEA

Ondansetron tab, 4mg DEA

Promethazine HCI tab, 25 mg

DEA elixir, 5 mg/5 mL inj, 25 mg/mL, 2 mL amp

Prochlorperazine tab, 5mg CEB 16.3 Laxative and Cathartic medicines

Bisacodyl tab, 5mg DEA

Glycerol suppository (child) 2 g DEA

Lactulose soln, 3.1mg/5ml CVA

Liquid paraffin soln HVA 16.4 Medicines used in non-infected diarrhoea

Oral Rehydration Salts(ORS) Powder, sachets HVA

Resomal Powder, sachets DVA

Zinc tab, 20mg HVA

Codeine phosphate tab, 15mg DVA

Loperamide HCL tab, 2mg DEA 16.5 Antihaemorrhoid medicines

Bismuth subgallate Supp, 5g DEA

Combination suppositories (hydrocortisone acetate, Lignocaine gel, Zinc oxide, Allantoin)

Sup DEA 16.6 Antispasmodic medicines

Atropine sulphate inj, 600 mcg/ml, 1ml amp DVA

Hyoscine butylbromide inj, 20mg/ml, 1ml DEA 17 HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES 17.1 Adrenal hormones and synthetic substitutes

Dexamethasone inj, 4mg/ml,1 ml ampoule DVA

Dexamethasone tab,0.5mg DEA

Hydrocortisone inj, 100mg vial CVB

Prednisolone tab, 5mg DVA 17.2 Contraceptive medicines 17.2.1 Oral hormonal contraceptives

Levonorgestrel implant, 75mg DVA

Levonorgestrel tab, 0.75mg DEB

Norgestrel + ethinylestradiol tab, 0.3mg + 0.03mg HVA

Norgestrel tab, 0.75mg HVA 17.2.2 Injectable hormonal contraceptives

Medroxyprogesterone acetate Inj, aq susp, 150mg/ml, 10ml vial HVA 17.2.3 Intra-uterine devices (IUD)

Copper containing IUD wire, 176mg DVB 17.2.4 Barrier contraceptives

Female condoms pack DVA

Male condoms pack DVA 17.2.5 Implantable contraceptives

Levonorgestrel releasing plant Rod, 75mg DVA 17.2.6 Oestrogen Medicine

Oestrogens, conjugated tab, 625mcg CEB 17.2.7 Ovulation Inducers

Clomiphene citrate tab, 50mg CEB 17.2.8 Progestogens

Noresthiosterone tab, 5mg CEA 17.3 Insulin and other medicines used for diabetes

Abiglutide inj, 30mg/0.5ml CEB

Canaglifozin tab, 100mg CEB

Dapaglifozin tab, 10mg CEB

Desmopressin inj, 4mcg/ml CEB

Dulaglutide inj, 0.75mg/0.5ml CEB

Empaglifozin tab, 10mg CEB

Exenatide tab, 2mg CEB

Glibenclamide tab, 5 mg DVA

Gliclazide tab, 80mg CEB

Glimepiride tab, 2mg CEB

Insulin, soluble inj, 100 iu/mL, 10ml DVA

Insulin zinc suspension inj, 100 iu/mL, 10ml DVA

Liraglutide inj, 6mg/ml CEB

Lixisenatide inj, 20mcg/ml CEB

Metformin HCI tab, 500 mg

DVA tab,850mg

Pioglitazone tab, 50mg CEB

Sitagliptin tab, 25mg CEB

Saxagliptin tab, 2.5mg CEB

Vildagliptin tab, 50mg CEB 17.4 Thyroid hormones and antithyroid medicines

Carbimazole tab, 5mg CVA

Iodine aqueous soln, oral, 30 mL DEA

Levothyroxine tab, 0.05mg CVB

Propylthiouracil tab, 50mg CVB

Radioiodine CEB

Thyroxine sodium tab, 100mcg CVA 18 Diuretics

Mannitol Inj, 15-20% DVA 19 Immunologicals 19.1 Immunological diagnostic agents

Tuberculin inj, 1ml vial DVA 19.2 Sera Immunoglobulins

Anti D immunoglobulin (RhoGAM) inj, 250mcg/ml, ampoule DVA

Anti-rabies Serum inj, 30IU/ml, 1ml DVA

Diptheria antitoxin inj, 20000IU/vial DVA

Polyvalent Snake Antivenom Inj, 40000IU/vial DVA

Tetenus antitoxin inj, 20000IU/vial DVA 19.3 Vaccines

Astrazenecca inj, 0.5ml HVA

BCG vaccine inj, 20 dose vial HVA

Covid-19 vaccine inj, 20 dose 10ml vial HVA

Diptheria-Pertusisis-Tetenus (DPT) inj, 20-dose 10ml vial HVA

Human Papilloma Virus (HPV) inj,10 single doses, 0.5ml vials HVA

Johnson & Johnson inj, 0.5ml HVA

Malaria vaccine inj, 20ml vial HVA

Measles vaccine, live PFR inj, 10 dose, 5ml vial HVA

Moderna injection HVA

Poliomyelitis vaccine oral susp, 20 dose dispenser HVA

Tetaenus toxoid vaccine inj, 10ml vial HVA

Pentavalent vaccine (Diptheria, Tetenus, Pertussis, Hepatitis B, Heamophilus influenza) inj, 2 dose vial HVA

Pfizer Injection HVA

Inactivated Polio vaccine inj, 0.5ml dose HVA

Pneumococcal conjugate vaccine inj, 0.5ml prefilled syringes HVA

Rabies vaccine inj, 1 dose (0.5ml) vial DVA

Rotavirus vaccine Inj, PFR

Sinopharm injection HVA

Sinovac injection HVA

Yellow fever inj, 10 dose, 5ml vial CEB 20 Muscle relaxant (Peripheral acting) and cholinesterase inhibitors

Alcuronium chloride inj, 5 mg/mL, 2mL amp CEB

Edrophonium chloride inj, 10 mg/mL, 1 mL amp CVB

Neostigmine inj, 2.5 mg/mL, 1 mL CEB

Orphenadrine tab, 50mg CEB

Suxamethonum chloride inj, 50mg/ml, 2ml amp DVA

Vecuronium bromide inj, 10mg vial, PFR CEB 21 OPHTHALMOLOGICAL PREPARATIONS 21.1 Anti-infective agent

Aciclovir tab, 200mg

DVA tab, 400mg eye oint, 3%, 4.5g

Amphotericin B eye drops, 0.15% CEB

Ciprofloxacin eye drop, 0.3% DVA

Econazole eye oint, 1% 15g CEB

Erythromycin eye oint, 0.5%, 3.5g tube CEB

Ganciclovir inj, 500mg PFR vial

CEB tab, 500mg

Foscarnet inj, 24mg/ml, 250ml bottle CEB

Gentamicin eye drops, 0.3%, 5 mL HVA

Idoxuridine eye drops, 0.1%, 5 mL CEB

Miconazole eye drops, 1%, 10 mL CEB

Moxifloxacin eye drop, 0.3% CEB

Natamycin ophthalmic susp, 5% CEB

Neomycin + Dexamethasone eye drop HVA

Ofloxacin eye drop, 0.3% CVA

Povidone-iodine eye drop, 2.5% CVB

Tetracycline HCI eye oint, 1%, 3.5 g tube HVA

Tobramycin eye drops CVA

Valganciclovir tab, 450mg CEB

Voriconazole eye drop, 1%, 2% CEB 21.2 Anti-inflammatory and anti-histamine agents

Dexamethasone eye drops, 0.1%, 5 mL CVA

Emadastine eye drops, 0.05%,5ml CEB

Fluoromethalone eye drops 0.1%, 5ml CEB

Flucinolone acetonide implants, 0.59mg CEB

Ketotifen eye drops,0.025ml CEB

Methylprednisolone acetate inj, 40 mg/mL, 2 mL vial CEB

Nedocromil eye drops,2%, 5ml CEB

Olopatadine 0.1%, 0.2% eye drops, 0.1, 0.2% HVA

Prednisolone eye drops, 0.5%, 1% 5ml CEB

Sodium Chromoglycate eye drops, 0.2% HEB

Triamcinolone acetonide inj, 40mg/ml, 1ml vial CEB 21.3 Local anaesthetics

Amethocaine HCL eye drops, 1%, 10ml DEA 21.4 Miotics and antiglaucoma medicines 5-fluorouracil sub-conjuctiva 50mg/ml CVB

Absolute alcohol 96%, Retrobulbar CEB

Acetazolamide tab, 250 mg DVA

Acetazolamide inj, 500 mg vial PFR CEB

Aflibercept inj, intravitreal 2mg/0.05ml CEB

Apraclonidine Topical eye CEB

Bimatroprost eye drops, 0.03%, 3ml CEB

Brinzolamide eye drops, 1%, 5ml CEB

Bevacizumab inj, intravitreal 400mg/16ml CEB

Betaxolol eye drops, 0.25%, 0.25ml CEB

Brimonidine eye drops, 0.2%, 5ml CEB

Dorzolamide eye drops, 2%, 5ml CEB

Glycerol oral soln, 50% CEB

Latanoprost eye drops, 0.005%, 2.5ml CEB

Mitomycin C sub-conjuctiva 4mg/ml CEB

Pilocarpine HCI eye drops, 2%, 4% 10 mL CVA

Ranibizumab intravitreal, 0.5mg, 0.3% CEB

Timolol maleate eye drops, 0.25% CVA

Travoprost eye drops, 0.004%, 2.5ml CEB 21.5 Mydriatic and immunosupressant medicines

Atropine sulphate eye oint,0.5%-1%, 3.5 g tube DVA

Cyclopentolate HCI eye drops, 0.5%, 1%, 5 mL DEA

Mycophenolate Mofetil inj, 250mg/ml, 500mg/ml, 200mg/ml CEB

Tropicamide + Phenylephrine eye drops 0.75% + 2.5% CEB 21.6 Others

Ascorbic acid tab, 200mg DEB

Carmellose eye drops, 0.5%, 10ml DEB

Hypromellose eye drops 0.3 %, 0.5% DEB

Mannitol inj, 20% CVA

Sodium ascorbate eye drops, 10% DEB

Sodium Hyaluronate Sub tenon, 2% CEB

Tacrolimus eye drops, 0.1%,0.03% CVB 22 OBSTETRIC & GYNAECOLOGICAL MEDICINES 22.1 Oxytocics

Mifepristone tab, 10mg DVA

Misoprostol tab, 200mcg tab, 200mcg DVA

Oxytocin inj, 10 IU/ml, 1ml HVA 22.2 Antioxytocics

Nifedipine tab, 10mg DVA

Nifedipine tab, 20mg SR DVA 22.3 Myometrial relaxants

Salbutamol sulphate inj, 1mg/ml, 5ml amp DVA 22.4 Medicine used in pre-enclampsia and eclampsia

Calcium gluconate inj, 10%, 100mg/ml, vial CVA

Dexamethone inj, 4mg/ml, ml DEB

Hydralazine Inj, 20mg/ml, 1ml amp DVB

Labetalol inj, 5mg/ml, 20ml CEB

Lignocaine Inj, 1% DVA

Magnesium Sulphate inj, 500mg/ml, 10ml vial HVA

Methylodopa tab, 500mg DVA

Nifedipine tab, 10mg DVA 22.5 Medicines used in primary PPH

Oxytocin inj, 10 IU/mL, 1 mL amp HVA

Misoprostol tab, 200mcg DVA 23 PERITONIAL DIALYSIS SOLUTIONS

Dianeal + dextrose 1.5% intraperitoneal dialysis, soln, 1L bottle CVB 4.25 % intraperitoneal dialysis, soln, 1L bottle 24 MEDICINE FOR MENTAL AND BEHAVIOUR DISORDER 24.1 Medicines used in psychotic disorder

Chlorpromazine HCI tab, 100 mg, 25mg DVA

Chlorpromazine HCI inj, 25 mg/mL, 2 mL amp HEA

Fluphenazinedecanoate inj, oily, 25 mg/mL, 2ml DVA

Fluoxetine cap, 10mg, 20mg DVA

Haloperidol tab, 1.5 mg, 5mg DEA

Haloperidol decanoate inj, oil, 50 mg/mL, 1 mL amp DEB

Olanzapine tab, 10mg CVA

Risperidone tab, 0.5 mg, 1mg, 2mg DVA

Sodium Valproate tab(crushable), 100mg, 500mg CEB 24.2 Medicines used in mood disorders 24.2.1 Medicines used in depressive disorders

Amitriptyline HCI tab , 25 mg HVA

Amitriptyline HCI inj, 10 mg/mL CVA

Fluoxetine tab, 20mg DVA

Sertraline tab, 50mg 24.2.2 Medicines used in bipolar disorders

Chlorpromazine HCI tab, 25mg, 100mg DVA

Haloperidol tab, 1.5 mg, 5mg DEA

Lithium tab, 0.25 - 2g CVA 24.2.3 Medicines used in anxiety

Diazepam inj, 5mg/ml, 2ml DVA tab, 5mg DEA

Lorazepam tab, 1mg HEA 24.2.4 Medicines used for disorders due to psychoactive substance use

Thiamine inj, 100ml DEB

• 25. ANTIPARKISONISM MEDICINES

Trihexyphenidyl tab, 5mg CEB 26 MEDICINES ACTING ON THE RESPIRATORY TRACT